you are here: Home News Ema

Ema

Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
Why top Silicon Valley executives are investing in new AI startup Ema
Former Coinbase CPO’s AI startup Ema raises $25 million from Wipro, Accel and others
Covid restrictions: Travelling to the US, or applying for a Green Card? Here's what you need to know
Exclusive | EMA to assess SII’s manufacturing site, says approval for Vaxzevria does not mean nod for Covishield
EXPLAINED | What is the exact mechanism for foreign vaccines to get approval in India?
EU recommends suspending hundreds of drugs tested by Micro Therapeutic Research Labs
3 top picks from Reliance Securities: Pidilite, Cipla & IOC
To cut healthcare costs, US must partner India: Biocon's Shaw
Biocon to see inspections by USFDA & EMA in April-May: Sources
USFDA to review Biocon-Mylan's biosimilar drug for breast cancer
Trastuzumab marketing approval may come in 12-18 months: Biocon
EMA accepts Mylan, Biocon Trastuzumab biosimilar for review
Alkem Labs falls 7% as German regulator accuses of data fudge
Alkem Labs accused of fudging trial data by German regulator
EU bans 700 generic drugs for manipulation of trials by GVK
World's first malaria vaccine gets nod from EU regulators
German regulator hails EMA's drugs suspension on GVK Bio
Riverbed Performance Mgmt Solution Recognised As A Value Leader By EMA
Sell Castorseed, RMSeed on pullback; buy CPO on dip: Geojit
Market to correct & then rally around 6100: Anil Manghnani
Buy Jeera, Turmeric on dip; sell RM Seed on pullback:Geojit
Sell Wheat below Rs 1510: Geojit Comtrade
Gold has target at USD 1500: India Forex
Buy Nifty future in 4625-4630 range: ICICIdirect.com

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Ema

Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant

Why top Silicon Valley executives are investing in new AI startup Ema

Former Coinbase CPO’s AI startup Ema raises $25 million from Wipro, Accel and others

Covid restrictions: Travelling to the US, or applying for a Green Card? Here's what you need to know

Exclusive | EMA to assess SII’s manufacturing site, says approval for Vaxzevria does not mean nod for Covishield

EXPLAINED | What is the exact mechanism for foreign vaccines to get approval in India?

EU recommends suspending hundreds of drugs tested by Micro Therapeutic Research Labs

3 top picks from Reliance Securities: Pidilite, Cipla & IOC

To cut healthcare costs, US must partner India: Biocon's Shaw

Biocon to see inspections by USFDA & EMA in April-May: Sources

USFDA to review Biocon-Mylan's biosimilar drug for breast cancer

Trastuzumab marketing approval may come in 12-18 months: Biocon

EMA accepts Mylan, Biocon Trastuzumab biosimilar for review

Alkem Labs falls 7% as German regulator accuses of data fudge

Alkem Labs accused of fudging trial data by German regulator

EU bans 700 generic drugs for manipulation of trials by GVK

World's first malaria vaccine gets nod from EU regulators

German regulator hails EMA's drugs suspension on GVK Bio

Riverbed Performance Mgmt Solution Recognised As A Value Leader By EMA

Sell Castorseed, RMSeed on pullback; buy CPO on dip: Geojit

Market to correct & then rally around 6100: Anil Manghnani

Buy Jeera, Turmeric on dip; sell RM Seed on pullback:Geojit

Sell Wheat below Rs 1510: Geojit Comtrade

Gold has target at USD 1500: India Forex

Buy Nifty future in 4625-4630 range: ICICIdirect.com